Rank | Gene Set | Z-score |
---|---|---|
1 | branching involved in prostate gland morphogenesis (GO:0060442) | 7.61248507 |
2 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 7.42269479 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.41063852 |
4 | protein retention in ER lumen (GO:0006621) | 7.28545745 |
5 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 7.27231397 |
6 | valine metabolic process (GO:0006573) | 6.93906395 |
7 | COPI coating of Golgi vesicle (GO:0048205) | 6.77644734 |
8 | Golgi transport vesicle coating (GO:0048200) | 6.77644734 |
9 | negative regulation of epidermal cell differentiation (GO:0045605) | 6.68306083 |
10 | transcytosis (GO:0045056) | 6.38006967 |
11 | exocrine pancreas development (GO:0031017) | 6.18611769 |
12 | beta-amyloid metabolic process (GO:0050435) | 6.17826826 |
13 | regulation of phospholipase A2 activity (GO:0032429) | 6.07982455 |
14 | cysteine metabolic process (GO:0006534) | 5.96603664 |
15 | intestinal cholesterol absorption (GO:0030299) | 5.85965233 |
16 | angiotensin maturation (GO:0002003) | 5.84740534 |
17 | intestinal epithelial cell development (GO:0060576) | 5.72734711 |
18 | response to testosterone (GO:0033574) | 5.28080273 |
19 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.07708461 |
20 | ovulation cycle (GO:0042698) | 5.06131325 |
21 | branched-chain amino acid metabolic process (GO:0009081) | 5.05718218 |
22 | negative regulation of epidermis development (GO:0045683) | 5.01626741 |
23 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.87667084 |
24 | acute-phase response (GO:0006953) | 4.84982100 |
25 | positive regulation of nuclease activity (GO:0032075) | 4.83448170 |
26 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.81660879 |
27 | digestion (GO:0007586) | 4.77385591 |
28 | branched-chain amino acid catabolic process (GO:0009083) | 4.76910288 |
29 | prostate gland epithelium morphogenesis (GO:0060740) | 4.74485842 |
30 | cellular modified amino acid catabolic process (GO:0042219) | 4.68897884 |
31 | epithelial cell maturation (GO:0002070) | 4.59296060 |
32 | sulfur amino acid catabolic process (GO:0000098) | 4.53712585 |
33 | mannose metabolic process (GO:0006013) | 4.53364694 |
34 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.49130300 |
35 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.46794416 |
36 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.39213964 |
37 | COPII vesicle coating (GO:0048208) | 4.38173760 |
38 | regulation of nuclease activity (GO:0032069) | 4.37168619 |
39 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.34908307 |
40 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.31111754 |
41 | daunorubicin metabolic process (GO:0044597) | 4.29923709 |
42 | polyketide metabolic process (GO:0030638) | 4.29923709 |
43 | doxorubicin metabolic process (GO:0044598) | 4.29923709 |
44 | mitochondrial calcium ion transport (GO:0006851) | 4.29157413 |
45 | peptide catabolic process (GO:0043171) | 4.28067686 |
46 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.26923164 |
47 | xenobiotic catabolic process (GO:0042178) | 4.17612110 |
48 | cellular response to unfolded protein (GO:0034620) | 4.17001583 |
49 | digestive system process (GO:0022600) | 4.09200472 |
50 | growth hormone secretion (GO:0030252) | 4.07611569 |
51 | response to endoplasmic reticulum stress (GO:0034976) | 4.01423856 |
52 | ER-nucleus signaling pathway (GO:0006984) | 4.01073656 |
53 | fucose metabolic process (GO:0006004) | 3.99698197 |
54 | positive regulation of growth hormone secretion (GO:0060124) | 3.98260165 |
55 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.93871470 |
56 | tetrapyrrole metabolic process (GO:0033013) | 3.90668534 |
57 | regulation of keratinocyte proliferation (GO:0010837) | 3.90369385 |
58 | cellular glucuronidation (GO:0052695) | 3.89957586 |
59 | cellular response to topologically incorrect protein (GO:0035967) | 3.87484890 |
60 | regulation of keratinocyte differentiation (GO:0045616) | 3.83642706 |
61 | glucuronate metabolic process (GO:0019585) | 3.83391927 |
62 | uronic acid metabolic process (GO:0006063) | 3.83391927 |
63 | lysine catabolic process (GO:0006554) | 3.83222547 |
64 | lysine metabolic process (GO:0006553) | 3.83222547 |
65 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.80179130 |
66 | homocysteine metabolic process (GO:0050667) | 3.79668045 |
67 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.78694562 |
68 | antibacterial humoral response (GO:0019731) | 3.77488263 |
69 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.76662717 |
70 | zinc ion transport (GO:0006829) | 3.75863991 |
71 | creatine metabolic process (GO:0006600) | 3.74932607 |
72 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.74821696 |
73 | artery development (GO:0060840) | 3.72121071 |
74 | membrane lipid catabolic process (GO:0046466) | 3.70038567 |
75 | nucleotide-sugar metabolic process (GO:0009225) | 3.69426628 |
76 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.68653344 |
77 | endocrine hormone secretion (GO:0060986) | 3.68358311 |
78 | acute inflammatory response (GO:0002526) | 3.66772971 |
79 | icosanoid secretion (GO:0032309) | 3.65135875 |
80 | arachidonic acid secretion (GO:0050482) | 3.65135875 |
81 | aspartate family amino acid catabolic process (GO:0009068) | 3.64776097 |
82 | sulfate transmembrane transport (GO:1902358) | 3.62400060 |
83 | lung secretory cell differentiation (GO:0061140) | 3.56990179 |
84 | short-chain fatty acid metabolic process (GO:0046459) | 3.56876308 |
85 | intestinal absorption (GO:0050892) | 3.55953973 |
86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.55508835 |
87 | L-phenylalanine metabolic process (GO:0006558) | 3.55508835 |
88 | drug transmembrane transport (GO:0006855) | 3.53509177 |
89 | galactose catabolic process (GO:0019388) | 3.52773957 |
90 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.52735085 |
91 | regulation of protein activation cascade (GO:2000257) | 3.50944444 |
92 | peptidyl-asparagine modification (GO:0018196) | 3.50667248 |
93 | negative regulation of protein activation cascade (GO:2000258) | 3.50086135 |
94 | antimicrobial humoral response (GO:0019730) | 3.48367252 |
95 | negative regulation of hormone metabolic process (GO:0032351) | 3.46804696 |
96 | proline metabolic process (GO:0006560) | 3.46137764 |
97 | cholesterol transport (GO:0030301) | 3.43964982 |
98 | sterol transport (GO:0015918) | 3.43964982 |
99 | proline biosynthetic process (GO:0006561) | 3.43156102 |
100 | vesicle coating (GO:0006901) | 3.40895432 |
101 | ceramide catabolic process (GO:0046514) | 3.40506260 |
102 | innate immune response in mucosa (GO:0002227) | 3.40478972 |
103 | regulation of cellular extravasation (GO:0002691) | 3.40281807 |
104 | glycolipid catabolic process (GO:0019377) | 3.35492105 |
105 | response to unfolded protein (GO:0006986) | 3.34556138 |
106 | fatty acid derivative transport (GO:1901571) | 3.34210541 |
107 | icosanoid transport (GO:0071715) | 3.34210541 |
108 | drug transport (GO:0015893) | 3.32322526 |
109 | regulation of cholesterol esterification (GO:0010872) | 3.32217496 |
110 | regulation of complement activation (GO:0030449) | 3.31395126 |
111 | mitochondrion distribution (GO:0048311) | 3.27830599 |
112 | epithelial structure maintenance (GO:0010669) | 3.25475982 |
113 | glycoside metabolic process (GO:0016137) | 3.25253693 |
114 | neutrophil mediated immunity (GO:0002446) | 3.24499369 |
115 | N-glycan processing (GO:0006491) | 3.24297385 |
116 | L-phenylalanine catabolic process (GO:0006559) | 3.24225331 |
117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.24225331 |
118 | glutathione derivative metabolic process (GO:1901685) | 3.24044702 |
119 | glutathione derivative biosynthetic process (GO:1901687) | 3.24044702 |
120 | peptidyl-proline hydroxylation (GO:0019511) | 3.23616846 |
121 | leukotriene biosynthetic process (GO:0019370) | 3.23280517 |
122 | protein N-linked glycosylation (GO:0006487) | 3.22981306 |
123 | 4-hydroxyproline metabolic process (GO:0019471) | 3.21079350 |
124 | phosphatidylserine metabolic process (GO:0006658) | 3.20092600 |
125 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.19656719 |
126 | N-acetylneuraminate metabolic process (GO:0006054) | 3.17949629 |
127 | complement activation, alternative pathway (GO:0006957) | 3.17616182 |
128 | L-fucose catabolic process (GO:0042355) | 3.17469518 |
129 | fucose catabolic process (GO:0019317) | 3.17469518 |
130 | L-fucose metabolic process (GO:0042354) | 3.17469518 |
131 | sulfur compound transport (GO:0072348) | 3.15887264 |
132 | response to topologically incorrect protein (GO:0035966) | 3.14709747 |
133 | regulation of metalloenzyme activity (GO:0048552) | 3.14211037 |
134 | cobalamin metabolic process (GO:0009235) | 3.14014143 |
135 | replicative senescence (GO:0090399) | 3.12861826 |
136 | regulation of pH (GO:0006885) | 3.10147004 |
137 | adult feeding behavior (GO:0008343) | 3.09567530 |
138 | anterior/posterior axis specification, embryo (GO:0008595) | 3.08947933 |
139 | regulation of triglyceride catabolic process (GO:0010896) | 3.08719594 |
140 | 2-oxoglutarate metabolic process (GO:0006103) | 3.08711578 |
141 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.08333735 |
142 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.07259976 |
143 | regulation of glucocorticoid secretion (GO:2000849) | 3.05019468 |
144 | GDP-mannose metabolic process (GO:0019673) | 3.04875837 |
145 | regulation of receptor binding (GO:1900120) | 3.04199598 |
146 | regulation of bile acid biosynthetic process (GO:0070857) | 3.03796073 |
147 | hormone catabolic process (GO:0042447) | 3.02752649 |
148 | transepithelial transport (GO:0070633) | 3.01131482 |
149 | cellular response to cadmium ion (GO:0071276) | 2.99723054 |
150 | L-serine transport (GO:0015825) | 2.98976907 |
151 | oxaloacetate metabolic process (GO:0006107) | 2.98747491 |
152 | water-soluble vitamin metabolic process (GO:0006767) | 2.97119600 |
153 | sphingolipid catabolic process (GO:0030149) | 2.93108997 |
154 | serine family amino acid metabolic process (GO:0009069) | 2.93038949 |
155 | peptide hormone processing (GO:0016486) | 2.92882426 |
156 | endocrine pancreas development (GO:0031018) | 2.91403845 |
157 | serine family amino acid biosynthetic process (GO:0009070) | 2.91215325 |
158 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.90846626 |
159 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.88280855 |
160 | regulation of cholesterol homeostasis (GO:2000188) | 2.88117631 |
161 | cellular response to zinc ion (GO:0071294) | 2.86803113 |
162 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.85720854 |
163 | positive regulation of wound healing (GO:0090303) | 2.84383823 |
164 | signal peptide processing (GO:0006465) | 2.81115874 |
165 | protein targeting to Golgi (GO:0000042) | 2.81064871 |
166 | cellular amino acid catabolic process (GO:0009063) | 2.79713868 |
167 | mucosal immune response (GO:0002385) | 2.79436727 |
168 | positive regulation of steroid hormone secretion (GO:2000833) | 2.79397305 |
169 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.78586587 |
170 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.77029635 |
171 | progesterone metabolic process (GO:0042448) | 2.76997121 |
172 | phospholipid efflux (GO:0033700) | 2.74747824 |
173 | organ or tissue specific immune response (GO:0002251) | 2.69879868 |
174 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.68703074 |
175 | reverse cholesterol transport (GO:0043691) | 2.66440414 |
176 | sphingomyelin metabolic process (GO:0006684) | 2.66255515 |
177 | alditol phosphate metabolic process (GO:0052646) | 2.66132487 |
178 | retinoid metabolic process (GO:0001523) | 2.65042713 |
179 | leukotriene metabolic process (GO:0006691) | 2.65041332 |
180 | phosphatidic acid biosynthetic process (GO:0006654) | 2.64461014 |
181 | phosphatidic acid metabolic process (GO:0046473) | 2.64461014 |
182 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.59171554 |
183 | negative regulation of complement activation (GO:0045916) | 2.56095398 |
184 | phenylpropanoid metabolic process (GO:0009698) | 2.55339235 |
185 | high-density lipoprotein particle remodeling (GO:0034375) | 2.51407691 |
186 | vitamin metabolic process (GO:0006766) | 2.50838537 |
187 | phospholipid homeostasis (GO:0055091) | 2.50447579 |
188 | diterpenoid metabolic process (GO:0016101) | 2.50255472 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.62862787 |
2 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.50154087 |
3 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.47392190 |
4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.06132771 |
5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.97995128 |
6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.97995128 |
7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.97995128 |
8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.90134032 |
9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.89456364 |
10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.87284720 |
11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.81704233 |
12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71448862 |
13 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.70629957 |
14 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.68822612 |
15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.58154963 |
16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.51766583 |
17 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.44947363 |
18 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.41921482 |
19 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.38231036 |
20 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.25264391 |
21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.23562157 |
22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.15688464 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14808901 |
24 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.06903024 |
25 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.02531789 |
26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.01717095 |
27 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.01145469 |
28 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.98418693 |
29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82532845 |
30 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.81198948 |
31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78969996 |
32 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78447738 |
33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77534619 |
34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.74801902 |
35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.74326740 |
36 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.72690825 |
37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70989086 |
38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70484668 |
39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70474295 |
40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67110259 |
41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65624624 |
42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63602015 |
43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63190486 |
44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62425355 |
45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56919356 |
46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54826081 |
47 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.53208196 |
48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52733913 |
49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49954329 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.49113092 |
51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46797239 |
52 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.43213574 |
53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.42396664 |
54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42349571 |
55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41739552 |
56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41088761 |
57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.40827670 |
58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39081263 |
59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37060121 |
60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36207421 |
61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34775429 |
62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29630295 |
63 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.25839013 |
64 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.25017831 |
65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23762465 |
66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22689844 |
67 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20721187 |
68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19961975 |
69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17593458 |
70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17593458 |
71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.16201727 |
72 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12536737 |
73 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.10850569 |
74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10665172 |
75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10304717 |
76 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08196816 |
77 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08121979 |
78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05682731 |
79 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05128894 |
80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04771519 |
81 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04209111 |
82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04152894 |
83 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04104393 |
84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02974577 |
85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02280727 |
86 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.01399199 |
87 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01199529 |
88 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.00163396 |
89 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99985592 |
90 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99588073 |
91 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.99548487 |
92 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99003169 |
93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97156348 |
94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97156348 |
95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95760092 |
96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95668297 |
97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95560020 |
98 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95063378 |
99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95020857 |
100 | NFYA_21822215_ChIP-Seq_K562_Human | 0.94866529 |
101 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.94553360 |
102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93810608 |
103 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93471622 |
104 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93469683 |
105 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93397133 |
106 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92951876 |
107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92892462 |
108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90536682 |
109 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.90479384 |
110 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89018281 |
111 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.88785518 |
112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88557128 |
113 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88188261 |
114 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87690349 |
115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.87046014 |
116 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87008757 |
117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86489243 |
118 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.85878118 |
119 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85851016 |
120 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85326810 |
121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85251163 |
122 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.85158497 |
123 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.84773453 |
124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84757272 |
125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84685908 |
126 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84581812 |
127 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84464647 |
128 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.84430044 |
129 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84368902 |
130 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.83744260 |
131 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.83744260 |
132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83376873 |
133 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82968828 |
134 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82252361 |
135 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82052283 |
136 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81791103 |
137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81603227 |
138 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.81576947 |
139 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80749542 |
140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79718011 |
141 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79601091 |
142 | AR_25329375_ChIP-Seq_VCAP_Human | 0.79447419 |
143 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78151992 |
144 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77881597 |
145 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77410915 |
146 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.76329620 |
147 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75204684 |
148 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75204684 |
149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74889184 |
150 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74057055 |
151 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.74025316 |
152 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73979735 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 6.48811817 |
2 | MP0001666_abnormal_nutrient_absorption | 5.68888295 |
3 | MP0010386_abnormal_urinary_bladder | 4.46941136 |
4 | MP0005220_abnormal_exocrine_pancreas | 3.63651489 |
5 | MP0001873_stomach_inflammation | 3.58333582 |
6 | MP0009840_abnormal_foam_cell | 3.53830437 |
7 | MP0005365_abnormal_bile_salt | 3.46003832 |
8 | MP0005310_abnormal_salivary_gland | 3.16640622 |
9 | MP0002139_abnormal_hepatobiliary_system | 3.07600578 |
10 | MP0004264_abnormal_extraembryonic_tissu | 2.91710707 |
11 | MP0005083_abnormal_biliary_tract | 2.90947385 |
12 | MP0005360_urolithiasis | 2.83262807 |
13 | MP0001765_abnormal_ion_homeostasis | 2.76490175 |
14 | MP0009780_abnormal_chondrocyte_physiolo | 2.63713221 |
15 | MP0000537_abnormal_urethra_morphology | 2.44068517 |
16 | MP0004885_abnormal_endolymph | 2.38669891 |
17 | MP0009643_abnormal_urine_homeostasis | 2.37460024 |
18 | MP0004043_abnormal_pH_regulation | 2.36765054 |
19 | MP0008004_abnormal_stomach_pH | 2.18331726 |
20 | MP0004019_abnormal_vitamin_homeostasis | 2.17826074 |
21 | MP0005332_abnormal_amino_acid | 2.15026422 |
22 | MP0001756_abnormal_urination | 2.14559032 |
23 | MP0002166_altered_tumor_susceptibility | 2.09323498 |
24 | MP0005647_abnormal_sex_gland | 1.98079046 |
25 | MP0005085_abnormal_gallbladder_physiolo | 1.95152719 |
26 | MP0001664_abnormal_digestion | 1.92717848 |
27 | MP0003868_abnormal_feces_composition | 1.84384618 |
28 | MP0005636_abnormal_mineral_homeostasis | 1.82703319 |
29 | MP0005084_abnormal_gallbladder_morpholo | 1.79042506 |
30 | MP0000538_abnormal_urinary_bladder | 1.70999143 |
31 | MP0001485_abnormal_pinna_reflex | 1.69270591 |
32 | MP0005058_abnormal_lysosome_morphology | 1.69021038 |
33 | MP0002254_reproductive_system_inflammat | 1.63297691 |
34 | MP0000613_abnormal_salivary_gland | 1.62400420 |
35 | MP0003011_delayed_dark_adaptation | 1.57399822 |
36 | MP0004147_increased_porphyrin_level | 1.56825711 |
37 | MP0003705_abnormal_hypodermis_morpholog | 1.55359917 |
38 | MP0002009_preneoplasia | 1.50163439 |
39 | MP0003183_abnormal_peptide_metabolism | 1.45396984 |
40 | MP0002006_tumorigenesis | 1.36919857 |
41 | MP0003252_abnormal_bile_duct | 1.36410392 |
42 | MP0002136_abnormal_kidney_physiology | 1.34925041 |
43 | MP0002796_impaired_skin_barrier | 1.33340477 |
44 | MP0005448_abnormal_energy_balance | 1.31250041 |
45 | MP0010678_abnormal_skin_adnexa | 1.29482411 |
46 | MP0005381_digestive/alimentary_phenotyp | 1.21910926 |
47 | MP0000604_amyloidosis | 1.21236974 |
48 | MP0001663_abnormal_digestive_system | 1.20530588 |
49 | MP0005275_abnormal_skin_tensile | 1.20334044 |
50 | MP0003300_gastrointestinal_ulcer | 1.19430471 |
51 | MP0008872_abnormal_physiological_respon | 1.18916236 |
52 | MP0005319_abnormal_enzyme/_coenzyme | 1.18552001 |
53 | MP0004947_skin_inflammation | 1.18420539 |
54 | MP0000858_altered_metastatic_potential | 1.17161813 |
55 | MP0006072_abnormal_retinal_apoptosis | 1.14332360 |
56 | MP0003953_abnormal_hormone_level | 1.12214098 |
57 | MP0001501_abnormal_sleep_pattern | 1.11754197 |
58 | MP0003195_calcinosis | 1.08436940 |
59 | MP0001944_abnormal_pancreas_morphology | 1.08009803 |
60 | MP0000462_abnormal_digestive_system | 1.07860999 |
61 | MP0010329_abnormal_lipoprotein_level | 1.06856048 |
62 | MP0003959_abnormal_lean_body | 1.05169867 |
63 | MP0009384_cardiac_valve_regurgitation | 1.03805105 |
64 | MP0000470_abnormal_stomach_morphology | 1.02676527 |
65 | MP0003638_abnormal_response/metabolism_ | 1.00322684 |
66 | MP0002876_abnormal_thyroid_physiology | 0.99980178 |
67 | MP0002693_abnormal_pancreas_physiology | 0.99099792 |
68 | MP0003866_abnormal_defecation | 0.98940615 |
69 | MP0002138_abnormal_hepatobiliary_system | 0.97301305 |
70 | MP0002098_abnormal_vibrissa_morphology | 0.97171449 |
71 | MP0010155_abnormal_intestine_physiology | 0.96931945 |
72 | MP0002909_abnormal_adrenal_gland | 0.95786495 |
73 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93681017 |
74 | MP0005166_decreased_susceptibility_to | 0.92992007 |
75 | MP0002837_dystrophic_cardiac_calcinosis | 0.90911293 |
76 | MP0002118_abnormal_lipid_homeostasis | 0.89921147 |
77 | MP0002277_abnormal_respiratory_mucosa | 0.89370291 |
78 | MP0003315_abnormal_perineum_morphology | 0.88520928 |
79 | MP0005408_hypopigmentation | 0.88370838 |
80 | MP0000747_muscle_weakness | 0.88135553 |
81 | MP0000534_abnormal_ureter_morphology | 0.86722602 |
82 | MP0001919_abnormal_reproductive_system | 0.86287082 |
83 | MP0003879_abnormal_hair_cell | 0.81473550 |
84 | MP0004272_abnormal_basement_membrane | 0.81185972 |
85 | MP0002896_abnormal_bone_mineralization | 0.78370562 |
86 | MP0005452_abnormal_adipose_tissue | 0.77774083 |
87 | MP0006054_spinal_hemorrhage | 0.74968545 |
88 | MP0000230_abnormal_systemic_arterial | 0.70639661 |
89 | MP0008469_abnormal_protein_level | 0.69907723 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 0.69404996 |
91 | MP0004270_analgesia | 0.69104355 |
92 | MP0005187_abnormal_penis_morphology | 0.68828654 |
93 | MP0000477_abnormal_intestine_morphology | 0.68403740 |
94 | MP0001764_abnormal_homeostasis | 0.66711567 |
95 | MP0005379_endocrine/exocrine_gland_phen | 0.66534618 |
96 | MP0003186_abnormal_redox_activity | 0.65686227 |
97 | MP0001845_abnormal_inflammatory_respons | 0.65363801 |
98 | MP0003724_increased_susceptibility_to | 0.65342168 |
99 | MP0000681_abnormal_thyroid_gland | 0.64433946 |
100 | MP0005451_abnormal_body_composition | 0.63164136 |
101 | MP0005645_abnormal_hypothalamus_physiol | 0.63156895 |
102 | MP0006082_CNS_inflammation | 0.61131186 |
103 | MP0002135_abnormal_kidney_morphology | 0.60477222 |
104 | MP0001299_abnormal_eye_distance/ | 0.60413090 |
105 | MP0008961_abnormal_basal_metabolism | 0.60289978 |
106 | MP0004233_abnormal_muscle_weight | 0.60102103 |
107 | MP0004782_abnormal_surfactant_physiolog | 0.59868888 |
108 | MP0000516_abnormal_urinary_system | 0.59818517 |
109 | MP0005367_renal/urinary_system_phenotyp | 0.59818517 |
110 | MP0003045_fibrosis | 0.59765929 |
111 | MP0000609_abnormal_liver_physiology | 0.59701167 |
112 | MP0008438_abnormal_cutaneous_collagen | 0.58477159 |
113 | MP0003943_abnormal_hepatobiliary_system | 0.57051177 |
114 | MP0000371_diluted_coat_color | 0.56677457 |
115 | MP0003806_abnormal_nucleotide_metabolis | 0.56518580 |
116 | MP0002928_abnormal_bile_duct | 0.56249358 |
117 | MP0010352_gastrointestinal_tract_polyps | 0.56134019 |
118 | MP0000013_abnormal_adipose_tissue | 0.55978266 |
119 | MP0001346_abnormal_lacrimal_gland | 0.55622577 |
120 | MP0002089_abnormal_postnatal_growth/wei | 0.55160504 |
121 | MP0000377_abnormal_hair_follicle | 0.55035854 |
122 | MP0003283_abnormal_digestive_organ | 0.54618712 |
123 | MP0003329_amyloid_beta_deposits | 0.54300526 |
124 | MP0004130_abnormal_muscle_cell | 0.53514725 |
125 | MP0002078_abnormal_glucose_homeostasis | 0.53100924 |
126 | MP0005165_increased_susceptibility_to | 0.52695660 |
127 | MP0005334_abnormal_fat_pad | 0.52143295 |
128 | MP0004185_abnormal_adipocyte_glucose | 0.51214251 |
129 | MP0000598_abnormal_liver_morphology | 0.51159688 |
130 | MP0003646_muscle_fatigue | 0.50957664 |
131 | MP0000490_abnormal_crypts_of | 0.50164673 |
132 | MP0005023_abnormal_wound_healing | 0.49962654 |
133 | MP0002163_abnormal_gland_morphology | 0.49769733 |
134 | MP0004742_abnormal_vestibular_system | 0.49150011 |
135 | MP0009642_abnormal_blood_homeostasis | 0.48976212 |
136 | MP0002295_abnormal_pulmonary_circulatio | 0.45721527 |
137 | MP0009764_decreased_sensitivity_to | 0.43281227 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Steatorrhea (HP:0002570) | 9.83413833 |
2 | Hypoproteinemia (HP:0003075) | 6.95679389 |
3 | * Exocrine pancreatic insufficiency (HP:0001738) | 6.11243867 |
4 | Hypoplasia of the uterus (HP:0000013) | 6.02261367 |
5 | Abnormality of cochlea (HP:0000375) | 5.92376332 |
6 | Aplasia involving bones of the extremities (HP:0009825) | 5.37587731 |
7 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.37587731 |
8 | Aplasia of the phalanges of the hand (HP:0009802) | 5.37587731 |
9 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 4.70502172 |
10 | Fibular aplasia (HP:0002990) | 4.67714368 |
11 | Vacuolated lymphocytes (HP:0001922) | 4.43265108 |
12 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 4.41241615 |
13 | * Pancreatitis (HP:0001733) | 4.26091608 |
14 | Vascular calcification (HP:0004934) | 4.20127396 |
15 | Abnormality of the 2nd finger (HP:0004100) | 4.19238955 |
16 | Aplasia/hypoplasia of the uterus (HP:0008684) | 4.00826622 |
17 | Morphological abnormality of the inner ear (HP:0011390) | 3.95338958 |
18 | Gout (HP:0001997) | 3.91366881 |
19 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.88802435 |
20 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.84775655 |
21 | Congenital sensorineural hearing impairment (HP:0008527) | 3.80896740 |
22 | Cardiovascular calcification (HP:0011915) | 3.76952429 |
23 | Hypobetalipoproteinemia (HP:0003563) | 3.72194581 |
24 | Abnormality of vitamin B metabolism (HP:0004340) | 3.62460921 |
25 | Spontaneous abortion (HP:0005268) | 3.60747685 |
26 | Hypoplastic nipples (HP:0002557) | 3.59081143 |
27 | Hyperglycinuria (HP:0003108) | 3.56725678 |
28 | Abnormality of urine glucose concentration (HP:0011016) | 3.42486711 |
29 | Glycosuria (HP:0003076) | 3.42486711 |
30 | Adactyly (HP:0009776) | 3.40582282 |
31 | Short hallux (HP:0010109) | 3.35427782 |
32 | Abnormality of vitamin metabolism (HP:0100508) | 3.29067437 |
33 | Late onset (HP:0003584) | 3.24423673 |
34 | Abnormality of chloride homeostasis (HP:0011422) | 3.18470525 |
35 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 3.17666848 |
36 | Goiter (HP:0000853) | 3.16404749 |
37 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.14189696 |
38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.11457170 |
39 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.08657846 |
40 | Mucopolysacchariduria (HP:0008155) | 3.08657846 |
41 | Thoracolumbar scoliosis (HP:0002944) | 3.08000397 |
42 | Abnormality of the common coagulation pathway (HP:0010990) | 3.02885792 |
43 | Complement deficiency (HP:0004431) | 3.00673024 |
44 | 2-3 toe syndactyly (HP:0004691) | 3.00578674 |
45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.95840496 |
46 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.95124871 |
47 | Limb-girdle muscle atrophy (HP:0003797) | 2.94942254 |
48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.93654184 |
49 | Abnormality of glycine metabolism (HP:0010895) | 2.93654184 |
50 | Long toe (HP:0010511) | 2.87329327 |
51 | Hypoglycemic coma (HP:0001325) | 2.84161763 |
52 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.83186205 |
53 | Protuberant abdomen (HP:0001538) | 2.83177611 |
54 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.79802902 |
55 | Hypomagnesemia (HP:0002917) | 2.79669668 |
56 | Rectal prolapse (HP:0002035) | 2.78323162 |
57 | Hypoplasia of the ulna (HP:0003022) | 2.76837006 |
58 | Popliteal pterygium (HP:0009756) | 2.76362903 |
59 | Glomerulonephritis (HP:0000099) | 2.76142356 |
60 | Xanthomatosis (HP:0000991) | 2.74936066 |
61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73827538 |
62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73827538 |
63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73827538 |
64 | Dysostosis multiplex (HP:0000943) | 2.72600779 |
65 | Shawl scrotum (HP:0000049) | 2.69786289 |
66 | Ketoacidosis (HP:0001993) | 2.68883163 |
67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.65754459 |
68 | Ketosis (HP:0001946) | 2.60440922 |
69 | Abnormal tarsal ossification (HP:0008369) | 2.60367012 |
70 | Abnormality of renal excretion (HP:0011036) | 2.55718922 |
71 | Hyperphosphatemia (HP:0002905) | 2.55017511 |
72 | Potter facies (HP:0002009) | 2.52836884 |
73 | Facial shape deformation (HP:0011334) | 2.52836884 |
74 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.50697029 |
75 | Increased CSF protein (HP:0002922) | 2.50253721 |
76 | Abnormal foot bone ossification (HP:0010675) | 2.48614040 |
77 | Abdominal distention (HP:0003270) | 2.48156736 |
78 | Hyperactive renin-angiotensin system (HP:0000841) | 2.47775831 |
79 | Malnutrition (HP:0004395) | 2.47470111 |
80 | Joint swelling (HP:0001386) | 2.46489924 |
81 | Hypoglycemic seizures (HP:0002173) | 2.46057656 |
82 | Mitral stenosis (HP:0001718) | 2.46042201 |
83 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44803707 |
84 | Large for gestational age (HP:0001520) | 2.42886823 |
85 | Hypolipoproteinemia (HP:0010981) | 2.42645748 |
86 | Proximal tubulopathy (HP:0000114) | 2.40156406 |
87 | Hyperglycinemia (HP:0002154) | 2.37610608 |
88 | Hyperphosphaturia (HP:0003109) | 2.37386546 |
89 | Abnormality of magnesium homeostasis (HP:0004921) | 2.35739316 |
90 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.35735109 |
91 | Tubulointerstitial nephritis (HP:0001970) | 2.34272238 |
92 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.33238301 |
93 | Arthropathy (HP:0003040) | 2.32628712 |
94 | Rimmed vacuoles (HP:0003805) | 2.32346421 |
95 | Aortic aneurysm (HP:0004942) | 2.31991988 |
96 | Thyroid carcinoma (HP:0002890) | 2.31327934 |
97 | Abnormal urine output (HP:0012590) | 2.30734189 |
98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.30444624 |
99 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.25925751 |
100 | Disproportionate short-trunk short stature (HP:0003521) | 2.25814220 |
101 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.24159620 |
102 | Ileus (HP:0002595) | 2.23841995 |
103 | Increased circulating renin level (HP:0000848) | 2.22997566 |
104 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.22964216 |
105 | Hyperparathyroidism (HP:0000843) | 2.21905603 |
106 | Abnormal cartilage morphology (HP:0002763) | 2.20579564 |
107 | Hypoplasia of the pons (HP:0012110) | 2.18359289 |
108 | Gingival bleeding (HP:0000225) | 2.16959052 |
109 | Hyperuricemia (HP:0002149) | 2.16930929 |
110 | Increased purine levels (HP:0004368) | 2.16930929 |
111 | Hyperglycemia (HP:0003074) | 2.16845606 |
112 | Hyperammonemia (HP:0001987) | 2.15300178 |
113 | Abnormality of purine metabolism (HP:0004352) | 2.15242617 |
114 | Retinal atrophy (HP:0001105) | 2.14640057 |
115 | Abnormality of complement system (HP:0005339) | 2.13764967 |
116 | Abnormality of the axillary hair (HP:0100134) | 2.11414123 |
117 | Abnormality of secondary sexual hair (HP:0009888) | 2.11414123 |
118 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10471291 |
119 | Metabolic alkalosis (HP:0200114) | 2.09990628 |
120 | Abnormality of the nasal septum (HP:0000419) | 2.06067502 |
121 | Nausea (HP:0002018) | 2.05138721 |
122 | Beaking of vertebral bodies (HP:0004568) | 2.04953597 |
123 | Congenital, generalized hypertrichosis (HP:0004540) | 2.04564476 |
124 | Barrel-shaped chest (HP:0001552) | 2.02441400 |
125 | Systemic lupus erythematosus (HP:0002725) | 2.00456229 |
126 | Hypergonadotropic hypogonadism (HP:0000815) | 1.99114502 |
127 | Hypokalemic alkalosis (HP:0001949) | 1.97586300 |
128 | Distal arthrogryposis (HP:0005684) | 1.96675245 |
129 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.96334526 |
130 | * Fat malabsorption (HP:0002630) | 1.95799532 |
131 | Short femoral neck (HP:0100864) | 1.93995736 |
132 | Abnormality of the pons (HP:0007361) | 1.92117072 |
133 | Abnormal urine phosphate concentration (HP:0012599) | 1.91919357 |
134 | Hepatocellular carcinoma (HP:0001402) | 1.89594114 |
135 | Dehydration (HP:0001944) | 1.89044906 |
136 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.86152995 |
137 | Synostosis of carpal bones (HP:0005048) | 1.85380916 |
138 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.85287089 |
139 | Nephritis (HP:0000123) | 1.82970582 |
140 | Congenital malformation of the right heart (HP:0011723) | 1.82839922 |
141 | Double outlet right ventricle (HP:0001719) | 1.82839922 |
142 | Villous atrophy (HP:0011473) | 1.82663454 |
143 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.82663454 |
144 | Abnormality of the renal cortex (HP:0011035) | 1.82315804 |
145 | Abnormality of proline metabolism (HP:0010907) | 1.81376848 |
146 | Hydroxyprolinuria (HP:0003080) | 1.81376848 |
147 | Polyuria (HP:0000103) | 1.81115034 |
148 | Cervical subluxation (HP:0003308) | 1.78932824 |
149 | Methylmalonic acidemia (HP:0002912) | 1.77972682 |
150 | Intrahepatic cholestasis (HP:0001406) | 1.77959634 |
151 | Tubulointerstitial fibrosis (HP:0005576) | 1.77874851 |
152 | Right ventricular cardiomyopathy (HP:0011663) | 1.76772444 |
153 | Abnormality of macrophages (HP:0004311) | 1.74821697 |
154 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.74597231 |
155 | Insulin resistance (HP:0000855) | 1.73556079 |
156 | Decreased circulating renin level (HP:0003351) | 1.73292390 |
157 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72684860 |
158 | Prolonged partial thromboplastin time (HP:0003645) | 1.71927548 |
159 | Generalized aminoaciduria (HP:0002909) | 1.71508506 |
160 | Hypoplasia of the odontoid process (HP:0003311) | 1.71481374 |
161 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71417892 |
162 | Lymphangioma (HP:0100764) | 1.70988750 |
163 | Renal tubular dysfunction (HP:0000124) | 1.70886618 |
164 | Abnormal pancreas size (HP:0012094) | 1.70638522 |
165 | Submucous cleft hard palate (HP:0000176) | 1.69764759 |
166 | Symptomatic seizures (HP:0011145) | 1.69757487 |
167 | Abnormal biliary tract morphology (HP:0012440) | 1.69641616 |
168 | Broad hallux (HP:0010055) | 1.69505181 |
169 | Osteomalacia (HP:0002749) | 1.68553366 |
170 | Abnormal sex determination (HP:0012244) | 1.67475335 |
171 | Sex reversal (HP:0012245) | 1.67475335 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 6.16931042 |
2 | AKT3 | 5.77557303 |
3 | ERN1 | 4.68226603 |
4 | OXSR1 | 4.60380675 |
5 | BCKDK | 4.51770414 |
6 | STK24 | 4.32682120 |
7 | MAP3K12 | 3.95425881 |
8 | TAOK3 | 3.78084176 |
9 | MST4 | 3.67054786 |
10 | LMTK2 | 2.97478830 |
11 | LATS1 | 2.89563661 |
12 | ACVR1B | 2.81938943 |
13 | FRK | 2.77089529 |
14 | GRK1 | 2.47004315 |
15 | WNK4 | 2.30088873 |
16 | EPHA3 | 2.26504629 |
17 | PIK3CG | 2.15581677 |
18 | SCYL2 | 1.99078845 |
19 | EEF2K | 1.94893437 |
20 | BMPR1B | 1.85574020 |
21 | FGFR4 | 1.75420913 |
22 | PRKG2 | 1.73694636 |
23 | SIK1 | 1.70644550 |
24 | FGFR3 | 1.69497436 |
25 | BMPR2 | 1.59385631 |
26 | MAPKAPK3 | 1.59263777 |
27 | MAP3K2 | 1.54407717 |
28 | NLK | 1.53850745 |
29 | MYLK | 1.50299014 |
30 | CASK | 1.46583077 |
31 | TRIB3 | 1.43303024 |
32 | MAP3K6 | 1.38061249 |
33 | PDK2 | 1.37549812 |
34 | LRRK2 | 1.31072131 |
35 | ERBB3 | 1.29310296 |
36 | PTK6 | 1.22781945 |
37 | MAP2K2 | 1.22134627 |
38 | DAPK2 | 1.20907121 |
39 | TNK2 | 1.20774359 |
40 | FER | 1.18436447 |
41 | PIK3CA | 1.14081826 |
42 | MAP3K9 | 1.13662241 |
43 | EIF2AK3 | 1.08772748 |
44 | INSRR | 1.07913445 |
45 | PKN2 | 1.07126174 |
46 | RPS6KB2 | 0.98414117 |
47 | ZAP70 | 0.94594661 |
48 | TTN | 0.93346833 |
49 | IRAK1 | 0.91834736 |
50 | ADRBK2 | 0.91638187 |
51 | PAK2 | 0.89414600 |
52 | WNK3 | 0.88634039 |
53 | PAK3 | 0.87989439 |
54 | STK10 | 0.84554167 |
55 | PRKCE | 0.80868715 |
56 | TGFBR2 | 0.79671569 |
57 | STK38L | 0.79337850 |
58 | TESK1 | 0.74509587 |
59 | NTRK3 | 0.74440433 |
60 | PRKCI | 0.72609230 |
61 | NUAK1 | 0.72081304 |
62 | PHKG1 | 0.71111821 |
63 | PHKG2 | 0.71111821 |
64 | FGFR2 | 0.67916655 |
65 | STK16 | 0.67689860 |
66 | TESK2 | 0.65996146 |
67 | DAPK1 | 0.64586625 |
68 | NME1 | 0.64323060 |
69 | MST1R | 0.64196652 |
70 | DAPK3 | 0.56575815 |
71 | EPHA2 | 0.54478152 |
72 | PDK3 | 0.54237368 |
73 | PDK4 | 0.54237368 |
74 | MAP3K7 | 0.54107777 |
75 | DMPK | 0.53886693 |
76 | MET | 0.52655430 |
77 | WNK1 | 0.51906529 |
78 | STK3 | 0.50793618 |
79 | CAMKK1 | 0.50682440 |
80 | MELK | 0.46998974 |
81 | MAP3K5 | 0.45850994 |
82 | ILK | 0.45664663 |
83 | PDGFRA | 0.44564204 |
84 | MAP3K3 | 0.43726037 |
85 | MTOR | 0.42789287 |
86 | ADRBK1 | 0.40368081 |
87 | STK38 | 0.40110070 |
88 | PASK | 0.40074099 |
89 | PRKAA2 | 0.39564559 |
90 | PRKACG | 0.39396104 |
91 | PTK2 | 0.38916726 |
92 | JAK2 | 0.38428222 |
93 | RIPK1 | 0.36479912 |
94 | BRSK2 | 0.36438791 |
95 | CSNK1A1 | 0.35435022 |
96 | MAP2K1 | 0.35171048 |
97 | TRPM7 | 0.34504659 |
98 | MAP3K8 | 0.34463132 |
99 | RET | 0.34408217 |
100 | PRKCA | 0.34333236 |
101 | MAP2K7 | 0.33923868 |
102 | DDR2 | 0.32551165 |
103 | NEK6 | 0.32449317 |
104 | LATS2 | 0.31944575 |
105 | FGFR1 | 0.31001866 |
106 | FLT3 | 0.30368360 |
107 | CDK8 | 0.30231177 |
108 | MAP4K2 | 0.30013135 |
109 | KSR2 | 0.28185836 |
110 | MAP3K1 | 0.27672406 |
111 | CDK19 | 0.27600588 |
112 | ROCK1 | 0.27124752 |
113 | PDPK1 | 0.26748383 |
114 | PAK4 | 0.26643067 |
115 | MAPK7 | 0.26614109 |
116 | ROCK2 | 0.26134514 |
117 | PRKAA1 | 0.25581482 |
118 | PDGFRB | 0.23643642 |
119 | IRAK3 | 0.23349375 |
120 | RPS6KA2 | 0.23059009 |
121 | ERBB2 | 0.20944060 |
122 | RPS6KB1 | 0.20930068 |
123 | EPHB1 | 0.20885321 |
124 | PDK1 | 0.20695278 |
125 | JAK1 | 0.20659553 |
126 | CDC42BPA | 0.20296996 |
127 | TAOK1 | 0.17390762 |
128 | PRKD1 | 0.15442088 |
129 | BMX | 0.15426382 |
130 | TYK2 | 0.14249508 |
131 | PRKCQ | 0.14124587 |
132 | EGFR | 0.12798862 |
133 | CSF1R | 0.12232142 |
134 | MAP3K4 | 0.11535299 |
135 | ICK | 0.11121508 |
136 | NTRK1 | 0.11076586 |
137 | MAP2K6 | 0.10884067 |
138 | GSK3A | 0.10647872 |
139 | JAK3 | 0.10161575 |
140 | SGK3 | 0.09912958 |
141 | PRKACB | 0.09318504 |
142 | PRKCZ | 0.09001346 |
143 | RPS6KA1 | 0.08351236 |
144 | MAP2K4 | 0.07605354 |
145 | FYN | 0.07326758 |
146 | AKT2 | 0.06807119 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 4.23213130 |
2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.77720636 |
3 | Pancreatic secretion_Homo sapiens_hsa04972 | 3.40186515 |
4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.36496778 |
5 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.24481056 |
6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.94629499 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.76876136 |
8 | Protein export_Homo sapiens_hsa03060 | 2.76187176 |
9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.68014804 |
10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.61449861 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.42186804 |
12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.07378410 |
13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00411526 |
14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.83590141 |
15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.80478766 |
16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.78854091 |
17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78664306 |
18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.78439954 |
19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69558924 |
20 | Mineral absorption_Homo sapiens_hsa04978 | 1.68886141 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68103746 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64772864 |
23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64359407 |
24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.57232745 |
25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54441442 |
26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.52183506 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50926078 |
28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.50877982 |
29 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.48363458 |
30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48353202 |
31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46232025 |
32 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.45926438 |
33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45814127 |
34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43068157 |
35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33125210 |
36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32831582 |
37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32276594 |
38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32097397 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32083040 |
40 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.29551924 |
41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19856761 |
42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19392451 |
43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18721222 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17396751 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15461054 |
46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11976924 |
47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11524688 |
48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07290779 |
49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.01185014 |
50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00542266 |
51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00296217 |
52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96623175 |
53 | Lysosome_Homo sapiens_hsa04142 | 0.93841612 |
54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91039313 |
55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90122174 |
56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87490427 |
57 | Bile secretion_Homo sapiens_hsa04976 | 0.85400404 |
58 | Peroxisome_Homo sapiens_hsa04146 | 0.76832880 |
59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76631796 |
60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76221930 |
61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75561306 |
62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73920170 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71734441 |
64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71009234 |
65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70448875 |
66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70024705 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69077340 |
68 | Tight junction_Homo sapiens_hsa04530 | 0.68242682 |
69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66847698 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 0.66508074 |
71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63289813 |
72 | Salivary secretion_Homo sapiens_hsa04970 | 0.60639001 |
73 | Prostate cancer_Homo sapiens_hsa05215 | 0.57948713 |
74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56244113 |
75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54979894 |
76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53029753 |
77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52554537 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.52436233 |
79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51855216 |
80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51710316 |
81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51326483 |
82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50938499 |
83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49742141 |
84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48716906 |
85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46693572 |
86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46554065 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45719651 |
88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43108128 |
89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40707933 |
90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38512297 |
91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38374097 |
92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37168284 |
93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36482209 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36325543 |
95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.32780899 |
96 | Bladder cancer_Homo sapiens_hsa05219 | 0.30570878 |
97 | Adherens junction_Homo sapiens_hsa04520 | 0.30271371 |
98 | Hepatitis C_Homo sapiens_hsa05160 | 0.28778207 |
99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28623602 |
100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27181831 |
101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23152153 |
102 | ABC transporters_Homo sapiens_hsa02010 | 0.23018283 |
103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.22695875 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21509905 |
105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.21272738 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21254286 |
107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20951593 |
108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19941542 |
109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19105057 |
110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18824608 |
111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18259216 |
112 | Insulin secretion_Homo sapiens_hsa04911 | 0.16826558 |
113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16582842 |
114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16472752 |
115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14691369 |
116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14349215 |
117 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.14252933 |
118 | Amoebiasis_Homo sapiens_hsa05146 | 0.12797506 |
119 | Influenza A_Homo sapiens_hsa05164 | 0.12693138 |
120 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.11842214 |
121 | Focal adhesion_Homo sapiens_hsa04510 | 0.11419147 |
122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11342047 |
123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10617773 |
124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10614389 |
125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.10458645 |
126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09923982 |
127 | Pertussis_Homo sapiens_hsa05133 | 0.09797341 |
128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.08021521 |
129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06918160 |